Chronic changes in skeletal muscle histology and function in peripheral arterial disease
- PMID: 8425290
- DOI: 10.1161/01.cir.87.2.413
Chronic changes in skeletal muscle histology and function in peripheral arterial disease
Abstract
Background: Peripheral arterial disease (PAD) is associated with an impairment in exercise performance and muscle function that is not fully explained by the reduced leg blood flow during exercise. This study characterized the effects of PAD on muscle function, histology, and metabolism.
Methods and results: Twenty-six patients with PAD and six age-matched control subjects were studied. Ten of the PAD patients had unilateral disease, which permitted paired comparisons between their diseased and nonsymptomatic legs. All PAD patients had a lower peak treadmill walking time and peak oxygen consumption than controls. Vascular disease (diseased leg in unilateral patients and the most severely diseased leg in bilateral patients) was associated with decreased calf muscle strength compared with control values. In patients with unilateral disease, the diseased legs had a greater percentage of angular fibers (indicating chronic denervation) and a decreased type II fiber cross-sectional area (expressed as percent of total fiber area) compared with the nonsymptomatic, or control, legs. In diseased legs, gastrocnemius muscle strength was correlated with the total calf cross-sectional area (r = 0.78, p < 0.05) and type II fiber cross-sectional area (r = 0.63, p < 0.05). Activities of citrate synthase, phosphofructokinase, and lactate dehydrogenase in all 26 PAD patients (most diseased leg) did not differ from control values. Despite a wide range in citrate synthase activity in PAD patients, activity of this enzyme was not correlated with muscle strength or treadmill exercise performance.
Conclusions: In patients with PAD, gastrocnemius muscle weakness is associated with muscle fiber denervation and a decreased type II fiber cross-sectional area. In contrast, the PAD patients displayed substantial heterogeneity in muscle enzyme activities that was not associated with exercise performance. Denervation and type II fiber atrophy may contribute to the muscle dysfunction in patients with PAD and further confirm that the pathophysiology of chronic PAD extends beyond arterial obstruction.
Similar articles
-
Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.Circ Res. 2015 Apr 24;116(9):1540-50. doi: 10.1161/CIRCRESAHA.114.303517. Circ Res. 2015. PMID: 25908727 Free PMC article. Review.
-
Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease.J Vasc Surg. 2005 May;41(5):802-7. doi: 10.1016/j.jvs.2005.01.037. J Vasc Surg. 2005. PMID: 15886664
-
Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease.J Appl Physiol (1985). 1996 Aug;81(2):780-8. doi: 10.1152/jappl.1996.81.2.780. J Appl Physiol (1985). 1996. PMID: 8872646 Clinical Trial.
-
Muscle mechanics: adaptations with exercise-training.Exerc Sport Sci Rev. 1996;24:427-73. Exerc Sport Sci Rev. 1996. PMID: 8744258 Review.
-
Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease.J Appl Physiol (1985). 1992 Jul;73(1):346-53. doi: 10.1152/jappl.1992.73.1.346. J Appl Physiol (1985). 1992. PMID: 1506390
Cited by
-
Multi-modality imaging for assessment of the microcirculation in peripheral artery disease: Bench to clinical practice.Am Heart J Plus. 2024 May 8;42:100400. doi: 10.1016/j.ahjo.2024.100400. eCollection 2024 Jun. Am Heart J Plus. 2024. PMID: 38779485 Free PMC article.
-
The joint profiles of cardiorespiratory fitness and muscle strength on daily physical activity levels in patients with symptomatic peripheral artery disease: A cross-sectional study.PLoS One. 2024 Mar 27;19(3):e0298289. doi: 10.1371/journal.pone.0298289. eCollection 2024. PLoS One. 2024. PMID: 38536843 Free PMC article.
-
Mitochondrial respiration in peripheral arterial disease depends on stage severity.J Cell Mol Med. 2024 Apr;28(8):e18126. doi: 10.1111/jcmm.18126. J Cell Mol Med. 2024. PMID: 38534092 Free PMC article.
-
Hybrid ultrasound and single wavelength optoacoustic imaging reveals muscle degeneration in peripheral artery disease.Photoacoustics. 2023 Dec 2;35:100579. doi: 10.1016/j.pacs.2023.100579. eCollection 2024 Feb. Photoacoustics. 2023. PMID: 38312805 Free PMC article.
-
IGF-1 Therapy Improves Muscle Size and Function in Experimental Peripheral Arterial Disease.JACC Basic Transl Sci. 2023 Mar 8;8(6):702-719. doi: 10.1016/j.jacbts.2022.12.006. eCollection 2023 Jun. JACC Basic Transl Sci. 2023. PMID: 37426532 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical